About: Dr. Kenneth Spielvogel, MD
Senior Medical Officer, Carrara Treatment Wellness & Spa
Dr. Kenneth Spielvogel Resume
Dr. Kenneth Spielvogel is a board-certified physician with nearly 30 years of clinical experience and a specialized focus on addiction medicine, metabolic health, hormonal optimization, and long-term recovery. As Senior Medical Officer at Carrara Treatment Wellness & Spa, he helps lead a physician-driven approach to recovery that integrates medical, psychological, and lifestyle interventions to support lasting healing.
A graduate of the George Washington University School of Medicine and residency-trained at the University of Colorado Health Sciences Center, Dr. Spielvogel is board-certified in Obstetrics and Gynecology. Throughout his distinguished career, he has cared for thousands of patients in areas including women's health, hormone replacement therapy, fertility, prenatal care, minimally invasive surgery, and preventive medicine.
Witnessing the devastating impact of substance use disorders on patients and families inspired Dr. Spielvogel to expand his focus into addiction medicine. He has since dedicated years of continuing education and clinical practice to the treatment of substance use disorders, integrating evidence-based addiction care into both inpatient and outpatient settings.
Today, Dr. Spielvogel is particularly interested in the intersection of addiction medicine, metabolic health, and recovery. His work explores the role of GLP-1 therapies, hormonal health, exercise physiology, body composition, and biomarker-driven care in reducing cravings, improving overall health, and supporting sustainable recovery outcomes.
Known for his compassionate, patient-centered approach, Dr. Spielvogel believes in building strong relationships with those he serves, helping individuals make informed decisions about their health and recovery. Fluent in Spanish, he is committed to delivering culturally competent care to diverse patient populations.
Education & Credentials
- Medical Degree: George Washington University School of Medicine
- Residency: University of Colorado Health Sciences Center
- Board Certification: American Board of Obstetrics & Gynecology
Affiliations
- Senior Medical Officer, Carrara Treatment Wellness & Spa
- Consultant and Clinical Care Team Member, One Method Treatment Center
- MemorialCare Medical Group Long Beach
- Pediatrix Medical Group
Areas of Expertise
- Addiction Medicine
- Substance Use Disorder Treatment
- Medication-Assisted Treatment (MAT)
- GLP-1 Therapies and Recovery
- Hormonal Health & HRT
- Metabolic Health & Longevity
- Women's Health
- Weight Management
- Recovery Planning & Relapse Prevention
- Family Education & Support
The Future of GLP-1 Medications in Addiction Medicine
The Future of GLP-1 Medications in Addiction Medicine Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment What is the future of GLP-1 medications in addiction medicine? While drugs like semaglutide and tirzepatide are currently...
GLP-1 and Nicotine Addiction: Can Semaglutide Help You Quit?
GLP-1 and Nicotine Addiction: Can Semaglutide Help You Quit? Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can GLP-1 receptor agonists like semaglutide help you quit smoking? While traditionally prescribed for type 2 diabetes...
Can GLP-1 Medications Help Reduce Opioid Cravings?
Can GLP-1 Medications Help Reduce Opioid Cravings? Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can GLP-1 medications help reduce opioid cravings? Recent clinical studies and real-world population data indicate that GLP-1 receptor agonists,...
Managing Nausea and GLP-1 Side Effects in Recovery
Managing Nausea and GLP-1 Side Effects in Recovery Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment How do you manage nausea during GLP-1 addiction treatment? While GLP-1 receptor agonists like semaglutide effectively reduce cravings,...
GLP-1 Agonists and Stimulant Addiction: What We Know
GLP-1 Agonists and Stimulant Addiction: What We Know Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can GLP-1 medications help treat stimulant addiction? Emerging clinical evidence and real-world database analyses indicate that GLP-1 receptor...
Semaglutide for Alcohol Use Disorder: What Research Shows
Semaglutide for Alcohol Use Disorder: What Research Shows Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Can semaglutide treat alcohol use disorder? Emerging clinical research indicates that semaglutide, a GLP-1 receptor agonist, significantly reduces...
Tirzepatide vs. Semaglutide for Substance Cravings
Tirzepatide vs. Semaglutide for Substance Cravings Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Which medication is more effective for reducing substance cravings, tirzepatide or semaglutide? Both suppress cravings by modulating the brain’s dopamine-driven...
Why GLP-1 Alone Is Not Enough for Addiction Recovery
Why GLP-1 Alone Is Not Enough for Addiction Recovery Medically Reviewed by Dr. Kenneth Spielvogel, MD, Senior Medical Officer at Carrara Treatment Is a GLP-1 medication alone sufficient for lasting addiction recovery? While GLP-1 receptor agonists like semaglutide effectively...
The GLP-1 Wake-Up Call: Get Strong or Get Frail
Learn how to define the best rehab in Malibu for your needs by looking beyond views and marketing to clinical depth, privacy, luxury amenities, and long-term support.
